Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer.

Mohammad GH, Vassileva V, Acedo P, Olde Damink SWM, Malago M, Dhar DK, Pereira SP.

Cancers (Basel). 2019 Sep 16;11(9). pii: E1372. doi: 10.3390/cancers11091372.

2.

Need for a universal thalassemia screening programme in India? A public health perspective.

Thiyagarajan A, Bhattacharya S, Sharma N, Srivastava A, Dhar DK.

J Family Med Prim Care. 2019 May;8(5):1528-1532. doi: 10.4103/jfmpc.jfmpc_90_19.

3.

Numerical and Experimental Study of Mechanisms Involved in Boiling Histotripsy.

Pahk KJ, Gélat P, Sinden D, Dhar DK, Saffari N.

Ultrasound Med Biol. 2017 Dec;43(12):2848-2861. doi: 10.1016/j.ultrasmedbio.2017.08.938. Epub 2017 Sep 28.

PMID:
28965719
4.

Vps33b is crucial for structural and functional hepatocyte polarity.

Hanley J, Dhar DK, Mazzacuva F, Fiadeiro R, Burden JJ, Lyne AM, Smith H, Straatman-Iwanowska A, Banushi B, Virasami A, Mills K, Lemaigre FP, Knisely AS, Howe S, Sebire N, Waddington SN, Paulusma CC, Clayton P, Gissen P.

J Hepatol. 2017 May;66(5):1001-1011. doi: 10.1016/j.jhep.2017.01.001. Epub 2017 Jan 9.

5.

Validation of the peak bilirubin criterion for outcome after partial hepatectomy.

van Mierlo KMC, Lodewick TM, Dhar DK, van Woerden V, Kurstjens R, Schaap FG, van Dam RM, Vyas S, Malagó M, Dejong CHC, Olde Damink SWM.

HPB (Oxford). 2016 Oct;18(10):806-812. doi: 10.1016/j.hpb.2016.06.003. Epub 2016 Jul 2.

6.

A Novel Approach to Ultrasound-Mediated Tissue Decellularization and Intra-Hepatic Cell Delivery in Rats.

Pahk KJ, Mohammad GH, Malago M, Saffari N, Dhar DK.

Ultrasound Med Biol. 2016 Aug;42(8):1958-67. doi: 10.1016/j.ultrasmedbio.2016.03.020. Epub 2016 May 13.

PMID:
27184248
7.

Pyruvate Kinase M2 and Lactate Dehydrogenase A Are Overexpressed in Pancreatic Cancer and Correlate with Poor Outcome.

Mohammad GH, Olde Damink SW, Malago M, Dhar DK, Pereira SP.

PLoS One. 2016 Mar 18;11(3):e0151635. doi: 10.1371/journal.pone.0151635. eCollection 2016.

8.

A novel rat model of liver regeneration: possible role of cytokine induced neutrophil chemoattractant-1 in augmented liver regeneration.

Dhar DK, Mohammad GH, Vyas S, Broering DC, Malago M.

Ann Surg Innov Res. 2015 Nov 2;9:11. doi: 10.1186/s13022-015-0020-3. eCollection 2015.

9.

Clinico-pathological profile of dengue syndrome: an experience in a tertiary care hospital, Dhaka, Bangladesh.

Uddin MN, Hossain MM, Dastider R, Hasan Z, Ahmed Z, Dhar DK.

Mymensingh Med J. 2014 Oct;23(4):774-80.

PMID:
25481600
10.

Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma.

Mohamed FE, Al-Jehani RM, Minogue SS, Andreola F, Winstanley A, Olde Damink SW, Habtesion A, Malagó M, Davies N, Luong TV, Dhillon AP, Mookerjee RP, Dhar DK, Jalan R.

Liver Int. 2015 Mar;35(3):1063-76. doi: 10.1111/liv.12626. Epub 2014 Jul 30.

PMID:
24990399
11.

Role of toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure.

Shah N, Montes de Oca M, Jover-Cobos M, Tanamoto K, Muroi M, Sugiyama K, Davies NA, Mookerjee RP, Dhar DK, Jalan R.

Liver Transpl. 2013 Jul;19(7):751-61. doi: 10.1002/lt.23655.

12.

Importance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure.

Balasubramaniyan V, Dhar DK, Warner AE, Vivien Li WY, Amiri AF, Bright B, Mookerjee RP, Davies NA, Becker DL, Jalan R.

J Hepatol. 2013 Jun;58(6):1194-200. doi: 10.1016/j.jhep.2013.01.023. Epub 2013 Jan 29.

PMID:
23376361
13.

Sinusoidal obstruction syndrome: correct dosing of monocrotaline and the validity of the rat model.

Ezzat T, Dhar DK, Olde Damink SW.

J Surg Oncol. 2013 Mar;107(4):448-9. doi: 10.1002/jso.23265. Epub 2012 Sep 18. No abstract available.

PMID:
22991282
14.

Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer.

Dhar DK, Olde Damink SW, Brindley JH, Godfrey A, Chapman MH, Sandanayake NS, Andreola F, Mazurek S, Hasan T, Malago M, Pereira SP.

Cancer. 2013 Feb 1;119(3):575-85. doi: 10.1002/cncr.27611. Epub 2012 Aug 1.

15.

Dynamic tracking of stem cells in an acute liver failure model.

Ezzat T, Dhar DK, Malago M, Olde Damink SW.

World J Gastroenterol. 2012 Feb 14;18(6):507-16. doi: 10.3748/wjg.v18.i6.507.

16.

The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.

Ezzat T, van den Broek MA, Davies N, Dejong CH, Bast A, Malagó M, Dhar DK, Olde Damink SW.

J Surg Oncol. 2012 Jul 1;106(1):72-8. doi: 10.1002/jso.23046. Epub 2012 Jan 27.

PMID:
22287334
17.

Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer.

Chapman MH, Sandanayake NS, Andreola F, Dhar DK, Webster GJ, Dooley JS, Pereira SP.

J Clin Exp Hepatol. 2011 Jun;1(1):6-12.

18.

Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?

Ezzat TM, Dhar DK, Newsome PN, Malagó M, Olde Damink SW.

Liver Int. 2011 Jul;31(6):773-84. doi: 10.1111/j.1478-3231.2011.02530.x. Epub 2011 Apr 19. Review.

PMID:
21645208
19.

R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.

Matull WR, Dhar DK, Ayaru L, Sandanayake NS, Chapman MH, Dias A, Bridgewater J, Webster GJ, Bong JJ, Davidson BR, Pereira SP.

Liver Int. 2011 Jan;31(1):99-107. doi: 10.1111/j.1478-3231.2010.02345.x. Epub 2010 Sep 16.

20.

Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.

Sandanayake NS, Church NI, Chapman MH, Johnson GJ, Dhar DK, Amin Z, Deheragoda MG, Novelli M, Winstanley A, Rodriguez-Justo M, Hatfield AR, Pereira SP, Webster GJ.

Clin Gastroenterol Hepatol. 2009 Oct;7(10):1089-96. doi: 10.1016/j.cgh.2009.03.021. Epub 2009 Apr 1.

PMID:
19345283
21.

Kartagener's Syndrome.

Dhar DK, Ganguly KC, Alam S, Hossain A, Sarker UK, Das BK, Haque MJ.

Mymensingh Med J. 2009 Jan;18(1):75-9.

PMID:
19182755
22.

Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.

Yamamoto Y, Ono T, Dhar DK, Yamanoi A, Tachibana M, Tanaka T, Nagasue N.

J Gastroenterol Hepatol. 2008 Jun;23(6):930-7. doi: 10.1111/j.1440-1746.2008.05370.x.

PMID:
18565023
23.

Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis.

Tonomoto Y, Tachibana M, Dhar DK, Onoda T, Hata K, Ohnuma H, Tanaka T, Nagasue N.

Oncology. 2007;73(5-6):346-56. doi: 10.1159/000135350. Epub 2008 May 26.

PMID:
18500170
24.

Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer.

Hata K, Dhar DK, Watanabe Y, Nakai H, Hoshiai H.

Eur J Cancer. 2007 Jun;43(9):1452-9. Epub 2007 Apr 17.

PMID:
17442564
25.

Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.

Dhar DK, Hattori S, Tonomoto Y, Shimoda T, Kato H, Tachibana M, Matsuura K, Mitsumoto Y, Little AG, Nagasue N.

Ann Thorac Surg. 2007 Apr;83(4):1265-72.

PMID:
17383324
26.

FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2.

Hattori S, Dhar DK, Hara N, Tonomoto Y, Onoda T, Ono T, Yamanoi A, Tachibana M, Tsuchiya M, Nagasue N.

Lab Invest. 2007 Jun;87(6):591-601. Epub 2007 Mar 5.

27.

Prognosis of patients with gastric carcinoma treated in remote island hospitals in Japan: a multivariable analysis.

Toneri M, Mitsumoto Y, Shimabukuro M, Sunagawa T, Itagaki T, Iida S, Kondo T, Matsuura K, Okeda J, Dhar DK.

Anticancer Res. 2006 Sep-Oct;26(5B):3621-5.

28.

Surgical treatment of superficial esophageal cancer.

Tachibana M, Kinugasa S, Shibakita M, Tonomoto Y, Hattori S, Hyakudomi R, Yoshimura H, Dhar DK, Nagasue N.

Langenbecks Arch Surg. 2006 Aug;391(4):304-21. Epub 2006 Jul 8. Review.

PMID:
16830151
29.

Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.

Dhar DK, Wang TC, Tabara H, Tonomoto Y, Maruyama R, Tachibana M, Kubota H, Nagasue N.

Clin Cancer Res. 2005 Sep 15;11(18):6472-8.

30.

Expression of hypoxia inducible factor-1alpha during liver regeneration induced by partial hepatectomy in rats.

Maeno H, Ono T, Dhar DK, Sato T, Yamanoi A, Nagasue N.

Liver Int. 2005 Oct;25(5):1002-9.

PMID:
16162160
31.
32.

Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.

Ohno S, Inagawa H, Dhar DK, Fujii T, Ueda S, Tachibana M, Ohno Y, Suzuki N, Inoue M, Soma G, Nagasue N.

Anticancer Res. 2005 Jan-Feb;25(1B):463-70.

33.

Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.

Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N.

Am J Surg. 2005 Jan;189(1):98-109.

PMID:
15701501
34.

Metastatic lymph node size and colorectal cancer prognosis.

Dhar DK, Yoshimura H, Kinukawa N, Maruyama R, Tachibana M, Kohno H, Kubota H, Nagasue N.

J Am Coll Surg. 2005 Jan;200(1):20-8.

PMID:
15631916
35.

Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression.

Yoshimura H, Dhar DK, Kohno H, Kubota H, Fujii T, Ueda S, Kinugasa S, Tachibana M, Nagasue N.

Clin Cancer Res. 2004 Dec 15;10(24):8554-60.

36.
37.

Postoperative pulmonary complications are associated with worse short- and long-term outcomes after extended esophagectomy.

Kinugasa S, Tachibana M, Yoshimura H, Ueda S, Fujii T, Dhar DK, Nakamoto T, Nagasue N.

J Surg Oncol. 2004 Nov 1;88(2):71-7.

PMID:
15499604
38.

En-bloc esophagectomy for esophageal cancer.

Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Tabara H, Nagasue N.

Am J Surg. 2004 Sep;188(3):254-60. Review.

PMID:
15450830
39.

Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma.

Dhar DK, Naora H, Kubota H, Maruyama R, Yoshimura H, Tonomoto Y, Tachibana M, Ono T, Otani H, Nagasue N.

Int J Cancer. 2004 Oct 10;111(6):868-72.

40.

Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells.

Onoda T, Ono T, Dhar DK, Yamanoi A, Fujii T, Nagasue N.

J Lab Clin Med. 2004 Apr;143(4):207-16.

PMID:
15085079
41.

Transforming growth factor-beta1 induced hepatocyte apoptosis--a possible mechanism for growth of colorectal liver metastasis.

Hayashi H, Kohno H, Ono T, Yamanoi A, Dhar DK, Ueda S, Rahman MA, Kubota H, Nagasue N.

Acta Oncol. 2004;43(1):91-7.

PMID:
15068326
42.

Expression of regenerating gene I in gastric adenocarcinomas: correlation with tumor differentiation status and patient survival.

Dhar DK, Udagawa J, Ishihara S, Otani H, Kinoshita Y, Takasawa S, Okamoto H, Kubota H, Fujii T, Tachibana M, Nagasue N.

Cancer. 2004 Mar 15;100(6):1130-6.

43.

The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients.

Ohno S, Inagawa H, Dhar DK, Fujii T, Ueda S, Tachibana M, Suzuki N, Inoue M, Soma G, Nagasue N.

Anticancer Res. 2003 Nov-Dec;23(6D):5015-22.

PMID:
14981961
44.

Extended esophagectomy with 3-field lymph node dissection for esophageal cancer.

Tachibana M, Kinugasa S, Yoshimura H, Dhar DK, Nagasue N.

Arch Surg. 2003 Dec;138(12):1383-9; discussion 1390. Review.

PMID:
14662544
45.

Prognostic significance of metastatic lymph node size in patients with gastric cancer.

Dhar DK, Kubota H, Kinukawa N, Maruyama R, Kyriazanos ID, Ohno S, Nagasue N.

Br J Surg. 2003 Dec;90(12):1522-30.

PMID:
14648731
46.

Transforming growth factor-beta1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats.

Ueda S, Yamanoi A, Hishikawa Y, Dhar DK, Tachibana M, Nagasue N.

Lab Invest. 2003 Nov;83(11):1595-603.

47.

Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line.

Hata K, Osaki M, Dhar DK, Nakayama K, Fujiwaki R, Ito H, Nagasue N, Miyazaki K.

Cancer Chemother Pharmacol. 2004 Jan;53(1):68-74. Epub 2003 Oct 21.

PMID:
14569416
48.

Impact of uncoupling protein-2 expression on the prognosis of gastric adenocarcinoma patients.

Kyriazanos ID, Dhar DK, Rahman MA, Ohno S, Kubota H, Kohno H, Nagasue N.

Dig Liver Dis. 2003 Aug;35(8):597-9. No abstract available.

PMID:
14567467
49.

Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial.

Tachibana M, Kinugasa S, Yoshimura H, Dhar DK, Ueda S, Fujii T, Kohno H, Nagasue N.

World J Surg. 2003 Jul;27(7):776-81.

PMID:
14509504
50.

Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer.

Dhar DK, Wang TC, Maruyama R, Udagawa J, Kubota H, Fuji T, Tachibana M, Ono T, Otani H, Nagasue N.

Lab Invest. 2003 Sep;83(9):1343-52.

Supplemental Content

Support Center